Navigation Links
Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors
Date:5/20/2013

EAST TAUNTON, Mass., May 20, 2013 /PRNewswire/ -- The Board of Directors of Orthopaedic Synergy, Inc. ("OSI")  whose subsidiary companies include OMNIlife science®, Inc., Enztec, Ltd., and Praxim, SA, have elected two experienced directors to their Board.  Guy Mayer , an experienced orthopaedic executive, will serve as the Chairman of the Board of Directors and David Johnson, an established medical device expert, will join as a director.

Before joining OSI as Board Chairman, Mr. Mayer served as President and Chief Executive Officer of Ascension Orthopedics, Inc. until it was acquired by Integra Life Science Holdings Corporation.  Prior to that role, Mr. Mayer was President, Chief Executive Officer and a Director of Tutogen Medical, Inc. where he played an instrumental role in the sale of Tutogen to RTI Biologics, Inc.  Mr. Mayer has also served as President and CEO of several other well known companies in the pharmaceutical and orthopaedic industry, including as President of Zimmer's Global Products Group. Currently Mr. Mayer also sits on the Board of Directors of Pivot Medical, Inc.

"I welcome the opportunity to serve as Chairman of OSI's Board of Directors, and look forward to working with the newly formed Board and the executive teams at OMNI, Enztec and Praxim.  While assisting OSI to deliver on the corporate mission and goals, I plan to focus on the strategic development and governance necessary to take the next step in the evolution of OSI and its subsidiaries," Mr. Mayer said in accepting his appointment.

The Board of Directors also appointed David Johnson as a Board member.  Mr. Johnson joins the Board with a broad spectrum of corporate management expertise and over 30 years experience leading private and public medical device companies.  Most recently he served as Chief Executive Officer of ConvaTec, Inc. Prior to this position he held senior level positions with Zimmer, Inc., Fisher Scientific, and Baxter Corporation.  He currently serves on the Board of Directors of Alliqua, Inc. 

George Cipolletti , Omni's Chief Executive Officer, stated he was thrilled with the additions of Guy and Dave to the Board of Directors. "They bring a wealth of strategic and industry experience that will help to facilitate the implementation of our aggressive growth initiatives.  Their business relationships and knowledge relating to strategic transactions, private equity and the capital markets will greatly benefit the company as we move forward."

About Orthopaedic Synergy, Inc.
Orthopaedic Synergy, Inc. functions as a holding company for its subsidiaries, OMNIlife science, Inc., (USA) Enztec Limited (New Zealand) and PRAXIM, SA. (France). Together these companies represent a global reconstructive orthopaedic concern that is committed to improving clinical outcomes through the design, manufacture and global distribution of high quality orthopaedic implants, as well as instrumentation and computer and robotics based surgical delivery systems for those implants. Providing a business and financial environment that encourages innovation, engineering excellence and shared business success in our subsidiary companies is the cornerstone of our corporate philosophy.   Additional information can be found at www.orthopedicsynergy.com.

About OMNIlife science, Inc.
OMNIlife science, Inc. was founded in 1999 as an organization committed to the design, manufacture and distribution of high quality orthopaedic devices. Our corporate headquarters are located in East Taunton, Massachusetts.  Our products are prescribed by orthopaedic surgeons for their patients who require total joint replacement.  OMNI is ISO 13485 certified and its products are FDA cleared and CE approved.  OMNI is emerging as a leader in modular hip stem technology and total knee replacement systems. We continue to challenge the design and functionality of our products based on continued advances in reconstructive surgical techniques, anatomic and biomechanical data, as well as input from surgeons. Our corporate strategic objectives include continued growth through line extensions to our hip and knee product offerings as well as the introduction of new products that will complement our current product portfolio and allow us to provide new clinical options for our customers. Additional information can be found at www.omnils.com.

 Contact:Lisa A. Cabral, MBACorporate Communications Manager617-549-1521lcabral@omnils.com
 


'/>"/>
SOURCE Orthopaedic Synergy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons
2. ORTHOWORLD(R) Announces FDA Official to Serve as Panelist at Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC(R))
3. Forum Tackles the Rising Costs, Challenges and Diminished Outcomes Associated with Treating Obese Patients for Orthopaedic Conditions
4. ESPN Chief Medical Correspondent Joins Orthopaedic Industry Leaders at OrthoTec 2013
5. Memorandum of Agreement: Training State Regulators to Advance the Quality of Orthopaedic Care for China
6. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
7. Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today
8. Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico
9. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
10. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
11. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
Breaking Medicine News(10 mins):